BSD Medical Corporation | Return to Homepage
Home    |    Contact us    |    Terms of Use    |    Privacy Statement    |    Site Map        
BSD Medical -- Delivering Thermal Energy to Medicine
About BSD Medical Products For Patients For Healthcare Professionals Investor Relations

Press Releases

  • 4/17/15 10:36 am MDT
    Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that the company has received clearance from the U.S. Food and Drug Administration (FDA) to market the MicroThermX® Microwave Ablation System (MicroThermX) for the specific indication of ablation procedures requiring partial or complete ablation of non-resectable liver tumors.Perseon Director Damian E. Dupuy, M.D. commented, “Thismore...
  • 4/8/15 10:11 am MDT
    Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that the company received clearance from the U.S. Food and Drug Administration (FDA) to market the MicroThermX® Microwave Ablation System (MicroThermX) for the specific indication of laparoscopic ablation procedures using image guidance. “This new indication increases the type of cases that our technology will be used for and themore...
  • 4/6/15 10:11 am MDT
    Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Brian A, Meltzer, M.D. as Chief Medical Officer and Vice President of Business Development, effective April 1, 2015.  Dr. Meltzer is a clinically trained physician with 15 years of expertise in the design and management of strategic growth programs and corporate ventures. “Brian’s career has encompassed allmore...
  • 4/2/15 10:21 am MDT
    Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced several filings with the Securities and Exchange Commission (SEC): preliminary proxy materials requesting stockholder approval for an amendment to the Company’s Amended and Restated Certificate of Incorporation, a transition report on Form 10-K for the period from September 1, 2014 to December 31, 2014; and a report on Form 8-K regardingmore...
  • 3/3/15 10:17 am MST
    Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that its Board of Directors is exploring strategic options to enhance shareholder value.  The Board has retained SunTrust Robinson Humphrey as its financial advisor to assist in this important initiative for the Company. “We have taken definitive steps over the past few months that have positioned the company for strong futuremore...
  • 2/26/15 9:15 am MST
    Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Jennifer R. Hoglin as Vice President of Global Marketing, effective February 17, 2015. Ms. Hoglin is an executive marketing professional with 20 years of experience in product, brand, and business development experience in primarily life sciences as well as multiple other industries.Clint Carnell, CEO of Perseon,more...
  • 2/24/15 11:53 am MST

    Perseon to Showcase its Leading Microwave Ablation Technology at 40th Annual Scientific Meeting of Society of Interventional Radiology (SIR)

    BSD Medical Corporation (NASDAQ:BSDM) (the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today unveiled its new name and corporate identity, Perseon Corporation (Perseon).  The Company’s new name is coupled with a new visual identity, including the new tagline “Science for Humanity.”“The change of our name to Perseon, a word with multiple references to our mission and technology, succinctly represents our focus as a pure play microwave ablationmore...
  • 2/17/15 7:20 am MST

     

    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Ben Beckham as Vice President of North American Sales, effective February 16, 2015.  Mr. Beckham is an accomplished and performance-driven life sciences executive with over 20 years of experience in medical sales management and marketing. Clint Carnell, CEO of BSD Medical, commented, “Ben’s signature strengths aremore...
  • 2/9/15 2:06 pm MST
    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the resignation of Gerhard W. Sennewald, Ph.D., and Douglas P. Boyd, Ph.D., as members of the Board of Directors. Mr. Boyd’s resignation was effective on January 28, 2015 and Mr. Sennewald’s resignation was effective February 4, 2015.“With our changing product focus, we are seeking new independent directors with vast life science andmore...
  • 1/29/15 10:50 am MST
    • Submits non-binding term sheet for hyperthermia assets

    • Commences monetization of real estate assets

    • Expects 180-day grace period extension from NASDAQ

    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today provided an update on its strategic plan for the Company first outlined on January 12, 2015.  As part of this plan, BSD intends to exit its hyperthermia product line this year and has submitted a non-binding term sheet for the potential sale of its assets.  Terms are still being negotiated; however, the Company expects to close the transactionmore...


Business Wire InvestorHQ℠